Chaple-Gil Alain Manuel, Santiesteban-Velázquez Meylin, Urbizo Vélez Joaquín Juan
Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago 7500912, Chile.
Instituto de Ciencias Básicas y Preclínicas (ICBP) "Victoria de Girón", Universidad de Ciencias Médicas de La Habana, La Habana 11300, Cuba.
Dent J (Basel). 2025 May 22;13(6):227. doi: 10.3390/dj13060227.
: Growing evidence suggests that oral microbiota dysbiosis may contribute to the development of systemic conditions, including neurodegenerative diseases. This dysregulation promotes immunoinflammatory responses that are increasingly associated with dementia. This systematic review aimed to evaluate the association between oral microbiota dysbiosis and the risk of dementia in older adults. : Eligible studies evaluated oral microbial composition using validated methods such as genetic sequencing, bacterial culture, or metagenomic analysis. Following PRISMA guidelines and a PICO framework, the review included cohort, case-control, and cross-sectional studies. Searches were conducted across PubMed, Scopus, Web of Science, Embase, and Cochrane Library. Two independent reviewers screened and selected studies, resolving disagreements through a third evaluator. : This systematic review revealed that , , , , , , , and spp. were consistently associated with Alzheimer's disease and mild cognitive impairment, indicating their potential role in neurodegeneration. In contrast, , , , , and were reduced in cognitively impaired individuals, suggesting a link with healthy cognition. Studies also showed decreased microbial diversity in Alzheimer's disease and the possible modifying effect of the APOE4 allele. Oral health interventions improved microbial composition and slowed cognitive decline, supporting the diagnostic and therapeutic potential of oral microbiota modulation. : The findings suggest that oral microbiota dysbiosis may not only result from cognitive decline but also contribute to its pathogenesis. Future studies with larger and more diverse cohorts are recommended to validate these associations.
越来越多的证据表明,口腔微生物群失调可能导致包括神经退行性疾病在内的全身性疾病的发展。这种失调会促进免疫炎症反应,而这种反应与痴呆症的关联日益增加。本系统评价旨在评估口腔微生物群失调与老年人患痴呆症风险之间的关联。:符合条件的研究使用基因测序、细菌培养或宏基因组分析等经过验证的方法评估口腔微生物组成。遵循PRISMA指南和PICO框架,该评价纳入了队列研究、病例对照研究和横断面研究。在PubMed、Scopus、Web of Science、Embase和Cochrane图书馆进行了检索。两名独立评审员筛选并选择研究,通过第三名评估员解决分歧。:本系统评价显示,[具体菌种1]、[具体菌种2]、[具体菌种3]、[具体菌种4]、[具体菌种5]、[具体菌种6]、[具体菌种7]和[具体菌种8]与阿尔茨海默病和轻度认知障碍始终相关,表明它们在神经退行性变中的潜在作用。相比之下,[具体菌种9]、[具体菌种10]、[具体菌种11]、[具体菌种12]和[具体菌种13]在认知受损个体中减少,表明与健康认知存在联系。研究还表明,阿尔茨海默病中微生物多样性降低,以及APOE4等位基因可能具有的调节作用。口腔健康干预改善了微生物组成并减缓了认知衰退,支持了口腔微生物群调节的诊断和治疗潜力。:研究结果表明,口腔微生物群失调可能不仅是认知衰退的结果,还可能导致其发病机制。建议未来开展更大规模、更多样化队列的研究来验证这些关联。